Sanofi India Ltd

Net profit of Sanofi India declined 12.52% to Rs 119.50 crore in the quarter ended March 2025 as against Rs 136.60 crore during the previous quarter ended March 2024. Sales rose 4.91% to Rs 535.90 crore in the quarter ended March 2025 as against Rs 510.80 crore during the previous quarter ended March 2024. ParticularsQuarter EndedMar. 2025Mar. 2024% Var. Sales535.90510.80 5 OPM %32.0826.84 - PBDT174.90140.30 25 PBT165.30131.20 26 NP119.50136.60 -13 Powered by Capital Market - Live

Sanofi India will hold a meeting of the Board of Directors of the Company on 14 May 2025.Powered by Capital Market - Live

The board of directors accepted Hrosz's resignation during a meeting held on 9 April and expressed appreciation for his significant contributions during his tenure. Hrosz will cease to be a key managerial personnel, senior management personnel, and a member of board committees at the close of business hours on 30 April 2025. Further, the board approved Hrosz's appointment as an additional non-executive director effective 1 May 2025, subject to shareholder approval, upon the recommendation of the nomination and remuneration committee (NRC). Sanofi India is among the leading multinational companies in the Indian pharmaceutical market. It offers a wide array of medicines for therapy areas such as diabetes, cardiology, thrombosis, the central nervous system, and antihistamines. The company's consolidated net profit declined 33.7% to Rs 91.30 crore in Q4 FY25 as against Rs 137.70 crore reported in Q4 FY24. Total revenue from operations grew by 9.7% year on year (YoY) to Rs 514.90 crore in the quarter ended 31 March 2024. Shares of Sanofi India rose 0.83% to Rs 6,100 on the BSE. Powered by Capital Market - Live

Sanofi India announced that the 69th Annual General Meeting(AGM) of the company will be held on 15 May 2025.Powered by Capital Market - Live

The key equity benchmarks traded with major losses in early trade due to ongoing FII selling and concerns over the tariffs situation. The Nifty dropped below 22,350 mark. All the sectoral indices on the NSE were traded in red with IT, auto and metals shares declining the most. At 09:25 IST, the barometer index, the S&P BSE Sensex, declined 751.63 points or 1% to 73,865. The Nifty 50 index dropped 224.55 points or 1% to 22,320.50. In the broader market, the S&P BSE Mid-Cap index declined 1.13% and the S&P BSE Small-Cap index fell 0.96%. The market breadth was weak. On the BSE, 606 shares rose and 2,253 shares fell. A total of 183 shares were unchanged. Foreign portfolio investors (FPIs) sold shares worth Rs 556.56 crore, while domestic institutional investors (DIIs) were net buyers to the tune of Rs 1,727.11 crore in the Indian equity market on 27 February 2025, provisional data showed. SEBI Leadership Change: Tuhin Kanta Pandey has been appointed as the 11th chairperson of the Securities and Exchange Board of India (SEBI) for a three-year term. The current Finance Secretary will replace Madhabi Puri Buch, who will complete her tenure as SEBI's first woman chairperson on Friday, February 28, 2025. Numbers to Track: The yield on India's 10-year benchmark federal paper advanced 1.65% to 6.820 as compared with the previous close of 6.818. In the foreign exchange market, the rupee edged lower against the dollar. The partially convertible rupee was hovering at 87,3750, compared with its close of 87.1800 during the previous trading session. MCX Gold futures for 4 April 2025 settlement were fell 0.39% to Rs 84,874. The US Dollar index (DXY), which tracks the greenback's value against a basket of currencies, was up 0.08% to 107.38. The United States 10-year bond yield advanced 0.75% to 4.281. In the commodities market, Brent crude for April 2025 settlement shed 30 cents or 0.41% to $73.74 a barrel. Stocks in Spotlight: Sanofi India jumped 3.79% after the company's standalone net profit jumped 31% Rs 91.3 crore in Q4 FY25 as compared with Rs 69.7 crore in Q4 FY24. Revenue increased 9.7% YoY to Rs 514.9 crore in Q4 FY25. Schaeffler India added 3.25% after the company's consolidated net profit increased 13.2% YoY to Rs 237.3 crore in Q4 FY25. Revenue jumped 14% YoY to Rs 2,136 crore in Q4 FY25. KSB rallied 6.59% after the company's reported 33.2% increase in consolidated net profit to Rs 73.1 crore on 20.5% jump in revenue to Rs 726.4 crore in Q4 FY25 over Q4 FY24. Global Market: Asian stocks fell on Friday after US President Donald Trump announced an additional 10% tax on Chinese imports, compounding the 10% tariff imposed earlier this month. Trump also reaffirmed plans to implement a 25% tariff on imports from Canada and Mexico, set to take effect on March 4. In Japan, factory output dipped 1.1% in January from the previous month, while retail sales climbed 3.9% year-over-year. Meanwhile, core consumer prices in Tokyo rose 2.2% in February. Wall Street ended sharply lower on Thursday, dragged down by a selloff in chip stocks and signs of a cooling economy. The Dow Jones Industrial Average fell 0.45% to 43,239.50, while the S&P 500 declined 1.59% to end at 5,861.57. The Nasdaq closed 2.78% lower at 18,544.42. Nvidia shares plunged 8.5% to $120.15, despite strong Q4 earnings that beat expectations. Investors remain wary of shrinking profit margins and rising costs tied to its Blackwell AI chip rollout. The US economy expanded at a 2.3% annualized rate in Q4 2024, unchanged from initial estimates but slower than Q3's 3.1% growth. For the full year, GDP grew 2.8%, slightly below 2023's 2.9%. Meanwhile, jobless claims surged unexpectedly, with 242,000 new applications filed last week--up 22,000 from the previous period. On a brighter note, new orders for US-manufactured capital goods jumped 0.8% in January, following a downwardly revised 0.2% rise in December.Powered by Capital Market - Live

Sanofi India announced that the Board of Directors of the Company at its meeting held on 27 February 2025, inter alia, have recommended the final dividend of Rs 117 per equity Share (i.e. 1170%) , subject to the approval of the shareholders.Powered by Capital Market - Live

Stocks to Watch: Sanofi India's standalone net profit jumped 31% Rs 91.3 crore in Q4 FY25 as compared with Rs 69.7 crore in Q4 FY24. Revenue increased 9.7% YoY to Rs 514.9 crore in Q4 FY25. Schaeffler India's consolidated net profit increased 13.2% YoY to Rs 237.3 crore in Q4 FY25. Revenue jumped 14% YoY to Rs 2,136 crore in Q4 FY25. KSB reported 33.2% increase in consolidated net profit to Rs 73.1 crore on 20.5% jump in revenue to Rs 726.4 crore in Q4 FY25 over Q4 FY24. Tata Power Company's solar manufacturing subsidiary, TP Solar, has received a Rs 632 crore contract from the Solar Energy Corporation of India (SECI) for the supply of 292.5 MWp DCR (Domestic Content Requirement) solar modules. Granules India said that the US Food and Drug Administration (USFDA) has issued a warning letter to Granules' Gagillapur facility based on its inspection conducted in August 2024. The warning letter may temporarily impact the FDA review of pending product submissions from this site until the issue is resolved. Servotech Renewable Power System has signed memorandum of understanding (MoU) with the Chamber of Indian Micro, Small, and Medium Enterprises (CIMSME) to significantly boost the adoption of solar energy across India. In support of the PM Surya Ghar Muft Bijli Yojana, they aim to install 1 lakh solar rooftop systems in homes by 2026. Rail Vikas Nigam (RVNL) received a letter of acceptance for a project worth Rs 135.66 crore from Central Railway. The project involves the design, supply, erection, testing, and commissioning of 132/55 KV traction substations, sectioning posts (SPs), and sub-sectioning posts (SSPs) in a 2 x 25 KV traction system (Scott-connected transformer) for the Bhusaval-Khandwa section of Central Railway, to meet the 3000 MT loading target on an EPC mode.Powered by Capital Market - Live

Net profit of Sanofi India declined 33.70% to Rs 91.30 crore in the quarter ended December 2024 as against Rs 137.70 crore during the previous quarter ended December 2023. Sales rose 9.74% to Rs 514.90 crore in the quarter ended December 2024 as against Rs 469.20 crore during the previous quarter ended December 2023. For the full year,net profit declined 31.45% to Rs 413.30 crore in the year ended December 2024 as against Rs 602.90 crore during the previous year ended December 2023. Sales rose 0.86% to Rs 2013.20 crore in the year ended December 2024 as against Rs 1996.10 crore during the previous year ended December 2023. ParticularsQuarter EndedYear EndedDec. 2024Dec. 2023% Var.Dec. 2024Dec. 2023% Var. Sales514.90469.20 10 2013.201996.10 1 OPM %22.9821.23 -24.3824.43 - PBDT123.80108.60 14 505.80547.20 -8 PBT114.2099.30 15 469.10510.70 -8 NP91.30137.70 -34 413.30602.90 -31 Powered by Capital Market - Live

Schaeffler India announced that the Board of Directors of the Company at its meeting held on 27 February 2025, has recommended a Final dividend of Rs.28 per share (i.e.1400%), subject to the approval of the shareholders.Powered by Capital Market - Live

Sanofi India will hold a meeting of the Board of Directors of the Company on 27 February 2025.Powered by Capital Market - Live